In agreement with our study, a previous analysis involving the ADNI cohort also found that baseline levels of CSF α-synuclein were not correlated to atrophy brain rates across the spectrum of normal aging, MCI, and AD (Mattsson et al., 2013). This evidence concerns the gene SNCA and Alzheimer disease.